Labshake search
Citations for Peprotech :
4601 - 4650 of 7700 citations since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Genetics 2022Quote: ... 20 ng/mL interleukin-3 (IL-3) (Peprotech) and 10 mM SR1 (StemCell) ...
-
bioRxiv - Developmental Biology 2022Quote: ... cells were cultured in the presence of 10 μM Y-27632 (ROCK inhibitor, Peprotech) for 24 hours in a humidified incubator at 37°C and 5% CO2.
-
bioRxiv - Developmental Biology 2022Quote: ... fibroblast growth factor 4 (FGF4, 25 ng/ml, 100-31, PeproTech), heparin (1 μg/ml ...
-
bioRxiv - Genetics 2022Quote: ... erythropoietin 50ng/ml (Peprotech 100-64), holo-transferrin 500ug/ml (Sigma T0665-100mg) ...
-
bioRxiv - Cancer Biology 2022Quote: ... and the human TGF-β (5 ng/mL) was added (Peprotech, Spain) for 48 hours ...
-
bioRxiv - Cancer Biology 2022Quote: ... EGF and FGF-2 (20 ng/ml) (PeproTech), glutamax (Thermo Fisher Scientific) ...
-
bioRxiv - Cancer Biology 2022Quote: ... Culture media for SKNO-1 cell line was supplemented with human GM-CSF (10 ng/mL, PeproTech). Cells tested negative for Mycoplasma by the MycoAlert PLUS Mycoplasma Detection Kit (Lonza) ...
-
bioRxiv - Genomics 2022Quote: ... IL-5 (10ng/mL; PeproTech Cat. 215-15), EPO (3U/mL ...
-
bioRxiv - Genomics 2022Quote: ... EPO (3U/mL; PeproTech Cat. 100-64), TPO (50ng/mL ...
-
bioRxiv - Immunology 2022Quote: ... rhIL15 (10 ng/ml) and rhIL7 (10 ng/ml) (Peprotech, Cranbury, NJ). PBMC were incubated overnight followed by addition of soluble anti-CD3 (5 μg/mL ...
-
bioRxiv - Systems Biology 2022Quote: ... IL-2 (Peprotech, 200-02-50μg) and tetravalent IL-2 (expressed and purified as described below ...
-
bioRxiv - Cancer Biology 2022Quote: ... BDNF (10 ng/ml, Cat# 450-02, Peprotech) and GDNF (10 ng/ml ...
-
bioRxiv - Microbiology 2022Quote: ... At 4-5 days post treatment of adherent cells with supplemented media containing M-CSF (Peprotech) and IL-1β (Peprotech) ...
-
bioRxiv - Immunology 2022Quote: ... 2ng/mL murine IL-7 (Peprotech) and 5ng/mL human FLT3L (Peprotech) ...
-
bioRxiv - Synthetic Biology 2021Quote: ... and 200 U/mL IL-2 (Peprotech), thereafter referred to as T cell growth medium ...
-
bioRxiv - Synthetic Biology 2021Quote: ... and 100 U/mL IL-2 (Peprotech). For MCF-7 killing ...
-
bioRxiv - Biophysics 2021Quote: ... the medium was replaced by RPMI containing 10% FCS and 20 ng/mL of Macrophage Colony-Stimulating Factor (M-CSF) (Peprotech). For experiments ...
-
bioRxiv - Biophysics 2021Quote: ... EMT in all cells lines were induced by addition of 5ng/ml Targeted Growth Factor-β1 (TGFβ1) (Peprotech, catalog no. 100-21-10UG) for 48 hours62.
-
bioRxiv - Cancer Biology 2021Quote: ... Organoids were stimulated with 200 ng/mL IFNγ (Peprotech) 24 hours before the experiment ...
-
bioRxiv - Cancer Biology 2021Quote: ... 50 ng/mL human recombinant EGF (Peprotech), 500 nM A83-01 (Tocris) ...
-
bioRxiv - Cancer Biology 2021Quote: ... were plated inside the upper mesh insert (100 µL volume) while either 200 ng/mL SDF-1α (#300-28A, PeproTech, Rocky Hill, NJ) or a monolayer of OP9 cells (1-2×104 cells/well ...
-
bioRxiv - Cancer Biology 2021Quote: ... SNKO-1 cells were obtained from DSMZ and cultured in RPMI with 10% FSB and 10 ng/ml GM-CSF (PeproTech). EOL-1 cells were obtained from DSMZ and cultured in RPMI with 10% FBS ...
-
bioRxiv - Cancer Biology 2021Quote: ... 20 ng/ml epidermal growth factor (Peprotech), 20ng/ml basic-fibroblast growth factor (Peprotech).
-
bioRxiv - Cancer Biology 2021Quote: ... 20ng/ml basic-fibroblast growth factor (Peprotech).
-
bioRxiv - Cancer Biology 2021Quote: ... and supplemented with murine SCF (10 ng/ml) and IL-3 (10 ng/ml) (Peprotech or BioLegend). The cells were serially passaged for ∼1 month ...
-
bioRxiv - Biophysics 2021Quote: ... and granulocyte-macrophage colony-stimulating factor (GM-CSF, 4 ng/mL, PeproTech, Canada) for four days ...
-
bioRxiv - Biophysics 2021Quote: ... bone marrow progenitor cells were cultured in complete RPMI media supplemented with interleukin-4 (IL-4, 10 ng/mL, PeproTech, Canada) and granulocyte-macrophage colony-stimulating factor (GM-CSF ...
-
bioRxiv - Biochemistry 2021Quote: ... 10 ng/mL BDNF (PeproTech), 10 ng/mL NT‐3 (PeproTech ...
-
bioRxiv - Biochemistry 2021Quote: ... 10 ng/mL NT‐3 (PeproTech) and 1 μg/mL Laminin (Gibco)) ...
-
bioRxiv - Biochemistry 2021Quote: ... Tubastatin A and SB431542 were dissolvedin Dimethyl sulfoxide(DMSO).They were configured in different concentrations:0μM,10μM,20μM.TGF-β1(Peprotech, USA), which is dissolved in phosphate buffered saline PBS ...
-
bioRxiv - Neuroscience 2021Quote: ... 20 ng/mL of EGF (Peprotech, AF-100-15), and 20 ng/mL of bFGF (Peprotech ...
-
bioRxiv - Cancer Biology 2021Quote: ... human fibroblast growth factor (FGF, 20 ng/ml; Peprotech) and Heparin (5 ug/ml ...
-
bioRxiv - Cancer Biology 2021Quote: ... 10 ng/ml recombinant human IL-8 (CXCL8; Peprotech), 20 ng/ml recombinant human GRO-α/MGSA (CXCL1 ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 25 ng/ml recombinant human HGF (Peprotech). Genomic DNA was isolated from individual clones with QuickExtract (Epicenter ...
-
bioRxiv - Cancer Biology 2021Quote: ... 20 ng/ml recombinant human GRO-α/MGSA (CXCL1; Peprotech), and 25 ng/ml recombinant human HGF (Peprotech) ...
-
bioRxiv - Cancer Biology 2021Quote: ... in a 96-well round bottom plate with 100U/mL rhIL-2 (Peprotech, Cat#200-02). Twenty-four hours after activation ...
-
bioRxiv - Cancer Biology 2021Quote: ... were assayed for CCL2 (PeproTech; 900-K126) and CXCL5 (Sigma ...
-
bioRxiv - Cancer Biology 2021Quote: ... 10 ng/ml bFGF (Peprotech, Hamburg, Germany) and SCF (0.5 % supernatant of SCF secreting CHO KLS cells) ...
-
bioRxiv - Cancer Biology 2021Quote: ... and the next day grown in the presence or absence of 100 IU/mL recombinant murine IFN-γ (PeproTech, Cranbury, NJ, Cat. No. 315-05) for 24 hours ...
-
bioRxiv - Cancer Biology 2021Quote: ... Recombinant IFN-γ (300-02) and anti-human IFN-γ antibody (506532) were purchased from PeproTech (Rocky Hill, USA). Etoposide (HY-13629 ...
-
bioRxiv - Cancer Biology 2021Quote: The cells were treated for 30 minutes (60 minutes after inhibitor treatment) with ligands in a 0,1% PBS/BSA carrier solution at the following concentrations: EGF (25 ng/mL, Peprotech), PDGF (10 ng/mL ...
-
bioRxiv - Cancer Biology 2021Quote: ... PDGF (10 ng/mL, Peprotech), NGF (50 ng/mL ...
-
bioRxiv - Cancer Biology 2021Quote: ... NGF (50 ng/mL, Peprotech) and IGF1 (100 ng/mL ...
-
bioRxiv - Cancer Biology 2021Quote: ... and IGF1 (100 ng/mL, Peprotech).
-
bioRxiv - Cancer Biology 2021Quote: ... 20 ng/ml basic fibroblast growth factor (FGF) (Peprotech). Spheres were analyzed 14 days after cell plating ...
-
bioRxiv - Cancer Biology 2021Quote: ... 20 ng/ml epidermal growth factor (EGF) (Peprotech), 20 ng/ml basic fibroblast growth factor (FGF ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 50 ng/mL EGF (Peprotech #AF-100-15). Wild-type cultures were also supplemented with 500 ng/mL R-spondin (R&D Systems #3474-RS) ...
-
bioRxiv - Cancer Biology 2021Quote: ... 100 ng/mL noggin (Peprotech #250-38) and 50 ng/mL EGF (Peprotech #AF-100-15) ...
-
bioRxiv - Cancer Biology 2021Quote: ... with or without the presence of 100 pg/ml recombinant human IFN-β (Peprotech). After 24 h incubation (37 °C ...
-
bioRxiv - Cancer Biology 2021Quote: ... were cultured in neurosphere conditions on non-adherent plates in serum free media supplemented with EGF (20 ng/mL; Peprotech), FGF2 (20 ng/mL ...